117 filings
Page 3 of 6
8-K
9d5n 1agni13at
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
pybd0xaidy
12 Dec 22
Other Events
5:36pm
8-K
n8bsomxcrsngonbu8
26 Oct 22
Other Events
7:06am
8-K
io3nm01r2456 jd1r79k
6 Oct 22
Nurix Therapeutics Reports Third Quarter Fiscal 2022 Financial Results and Provides a Corporate Update
4:10pm
8-K
z5iqnl
14 Sep 22
Nurix Therapeutics Appoints Leading Industry Strategist Edward C. Saltzman to its Board of Directors
4:01pm
8-K
wxg241woafgqxk lx8
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
424B5
74hyyc6 1wnc
8 Jul 22
Prospectus supplement for primary offering
4:10pm
424B5
fwh877q7edb 26
8 Jul 22
Prospectus supplement for primary offering
4:09pm
8-K
akkh 82to8i53sqbl6
7 Jul 22
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update
4:09pm
8-K
9j19npd6f3 sw3
26 May 22
Other Events
7:02am
8-K
mfwr i7q7
16 May 22
Departure of Directors or Certain Officers
6:08am
8-K
qb1is6 0k
6 May 22
Submission of Matters to a Vote of Security Holders
7:00am
8-K
01qwdbtew2yi d46
7 Apr 22
Nurix Therapeutics Reports Fiscal First Quarter 2022 Financial Results and Provides a Corporate Update
4:08pm
DEFA14A
a74t2kgr
25 Mar 22
Additional proxy soliciting materials
7:06am
8-K
1zaf0g
7 Mar 22
Departure of Directors or Certain Officers
4:05pm
8-K
n1n9exjoz61d
2 Mar 22
Entry into a Material Definitive Agreement
4:07pm